Literature DB >> 24423579

Twenty-five years of idiopathic calcium nephrolithiasis: has anything changed?

Antonio Nouvenne, Andrea Ticinesi, Franca Allegri, Angela Guerra, Loredana Guida, Ilaria Morelli, Loris Borghi, Tiziana Meschi.   

Abstract

Idiopathic calcium nephrolithiasis (ICN) is a disease whose prevalence is rising. Our aim was to assess whether lifestyle indicators and habits of calcium stone formers in Italy have changed over the last 25 years, trying to establish a connection with the diffusion of Internet access. Therefore we examined the database of the Stone Clinic of Parma University Hospital and extracted 1952 (1192 M, 760 F) patients with ICN who underwent a full clinical and laboratory evaluation from 1986 to 2010. Laboratory evaluation included data on urinary 24-h volume, pH, sodium, potassium, chloride, calcium, phosphate, uric acid, magnesium, oxalate, and citrate. Patients were split in three groups on a chronological basis, according to official EUROSTAT-ISTAT data of Internet connection among families in Italy: Group 1, pre-Internet era (1986-1998, 853 patients); Group 2, narrow-band era (1999-2004, 467 patients); Group 3, broad-band era (2005-2010, 632 patients). Over the time we found a significant increase in water intake (1.37 vs. 1.78 L in men and 1.21 vs. 1.55 L in women, Group 1 vs. Group 3, p-trend<0.001) and a decrease in urinary sodium and chloride for both genders and calcium and magnesium only for males, while females experienced a slight increase in oxalate excretion. Supersaturation indexes for calcium and uric acid stones dramatically fell for both genders. The percentage of stone formers performing physical activity significantly rise (41% Group 3 vs. 8% Group 1, p<0.001) and we also found a trend of reduction in mean blood pressure. Therefore, the lifestyle of Italian idiopathic calcium stone formers has changed over the last 25 years, and the rising Internet access may have played a great role in driving this change.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24423579     DOI: 10.1515/cclm-2013-0618

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  6 in total

1.  Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study.

Authors:  Angela Guerra; Andrea Ticinesi; Franca Allegri; Antonio Nouvenne; Silvana Pinelli; Fulvio Lauretani; Marcello Maggio; Gianfranco Cervellin; Loris Borghi; Tiziana Meschi
Journal:  Urolithiasis       Date:  2016-12-09       Impact factor: 3.436

2.  Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits.

Authors:  Andrea Ticinesi; Angela Guerra; Franca Allegri; Antonio Nouvenne; Gianfranco Cervellin; Marcello Maggio; Fulvio Lauretani; Loris Borghi; Tiziana Meschi
Journal:  J Nephrol       Date:  2017-10-31       Impact factor: 3.902

Review 3.  From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis.

Authors:  Johannes M Baumann; Beat Affolter
Journal:  World J Nephrol       Date:  2014-11-06

4.  The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25.

Authors:  Angela Guerra; Andrea Ticinesi; Franca Allegri; Antonio Nouvenne; Silvana Pinelli; Giuseppina Folesani; Fulvio Lauretani; Marcello Maggio; Loris Borghi; Tiziana Meschi
Journal:  Urolithiasis       Date:  2016-04-01       Impact factor: 3.436

Review 5.  Methods for the dietary assessment of adult kidney stone formers: a scoping review.

Authors:  Constance Legay; Tropoja Krasniqi; Alice Bourdet; Olivier Bonny; Murielle Bochud
Journal:  J Nephrol       Date:  2022-02-15       Impact factor: 3.902

Review 6.  Fad diets and their effect on urinary stone formation.

Authors:  Antonio Nouvenne; Andrea Ticinesi; Ilaria Morelli; Loredana Guida; Loris Borghi; Tiziana Meschi
Journal:  Transl Androl Urol       Date:  2014-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.